Bdh Industries [BDH] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Bdh Industries

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bdh Industries wins in 11 metrics, Suven Life Sciences wins in 7 metrics, with 0 ties. Bdh Industries appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBdh IndustriesSuven Life SciencesBetter
P/E Ratio (TTM)27.48-28.01Suven Life Sciences
Price-to-Book Ratio4.2140.49Bdh Industries
Debt-to-Equity Ratio1.430.00Suven Life Sciences
PEG Ratio1.66-0.34Suven Life Sciences
EV/EBITDA21.91-23.32Suven Life Sciences
Profit Margin (TTM)13.84%84.44%Suven Life Sciences
Operating Margin (TTM)10.21%-2,791.92%Bdh Industries
EBITDA Margin (TTM)10.21%N/AN/A
Return on Equity13.49%-146.15%Bdh Industries
Return on Assets (TTM)10.67%-118.91%Bdh Industries
Free Cash Flow (TTM)$145.56M$-1.91BBdh Industries
Dividend Yield2.98%N/AN/A
1-Year Return55.39%46.77%Bdh Industries
Price-to-Sales Ratio (TTM)4.21641.26Bdh Industries
Enterprise Value$2.60B$43.40BSuven Life Sciences
EV/Revenue Ratio3.77577.38Bdh Industries
Gross Profit Margin (TTM)26.19%100.00%Suven Life Sciences
Revenue per Share (TTM)$120$0Bdh Industries
Earnings per Share (Diluted)$18.32$-8.15Bdh Industries
Beta (Stock Volatility)0.200.86Bdh Industries
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bdh Industries vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Bdh Industries
Suven Life Sciences
Bdh Industries Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bdh Industries0.69%16.29%59.55%88.44%82.43%45.46%
Suven Life Sciences0.76%-0.17%-3.10%-15.83%58.82%63.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bdh Industries55.39%244.88%560.76%583.94%2,122.81%1,684.51%
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%

News Based Sentiment: Bdh Industries vs Suven Life Sciences

Bdh Industries

News based Sentiment: MIXED

BDH Industries experienced a significant stock price increase and positive developments in promoter holding, but these gains are offset by analyst concerns about overvaluation. This creates a mixed investment narrative, making October a noteworthy but not definitively positive month for the company.

View Bdh Industries News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Bdh Industries vs Suven Life Sciences

MetricBDHSUVEN
Market Information
Market Cap i₹3.02B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i16,703185,019
90 Day Avg. Volume i17,096147,095
Last Close₹506.80₹208.63
52 Week Range₹241.00 - ₹519.80₹102.50 - ₹299.99
% from 52W High-2.50%-30.45%
All-Time High₹519.80 (Oct 03, 2025)₹338.50 (Apr 13, 2015)
% from All-Time High-2.50%-38.37%
Growth Metrics
Quarterly Revenue Growth0.15%0.86%
Quarterly Earnings Growth0.17%0.86%
Financial Health
Profit Margin (TTM) i0.14%0.84%
Operating Margin (TTM) i0.10%-27.92%
Return on Equity (TTM) i0.13%-1.46%
Debt to Equity (MRQ) i1.430.00
Cash & Liquidity
Book Value per Share (MRQ)₹119.43₹5.04
Cash per Share (MRQ)₹54.12₹2.75
Operating Cash Flow (TTM) i₹227.86M₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹92.73M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i2.98%N/A
Last 12-Month Dividend i₹9.00₹0.00

Valuation & Enterprise Metrics Analysis: Bdh Industries vs Suven Life Sciences

MetricBDHSUVEN
Price Ratios
P/E Ratio (TTM) i27.48-28.01
Forward P/E i69.9110.55
PEG Ratio i1.66-0.34
Price to Sales (TTM) i4.21641.26
Price to Book (MRQ) i4.2140.49
Market Capitalization
Market Capitalization i₹3.02B₹48.20B
Enterprise Value i₹2.60B₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i3.77577.38
Enterprise to EBITDA i21.91-23.32
Risk & Other Metrics
Beta i0.200.86
Book Value per Share (MRQ) i₹119.43₹5.04

Financial Statements Comparison: Bdh Industries vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BDHSUVEN
Revenue/Sales i₹186.24M₹18.67M
Cost of Goods Sold i₹137.46M₹0
Gross Profit i₹48.79M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹19.01M₹-521.17M
EBITDA i₹26.63M₹-501.49M
Pre-Tax Income i₹24.41M₹-515.17M
Income Tax i₹6.14M₹0
Net Income (Profit) i₹18.27M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BDHSUVEN
Cash & Equivalents i₹307.12M₹150.26M
Total Current Assets i₹667.49M₹754.72M
Total Current Liabilities i₹169.17M₹234.86M
Long-Term Debt iN/AN/A
Total Shareholders Equity i₹687.62M₹1.10B
Retained Earnings i₹457.59M₹-6.01B
Property, Plant & Equipment i₹146.88M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BDHSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBDHSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i16,703185,019
Average Daily Volume (90 Day) i17,096147,095
Shares Outstanding i5.76M218.07M
Float Shares i2.21M67.61M
% Held by Insiders i0.57%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Bdh Industries vs Suven Life Sciences

MetricBDHSUVEN
Last 12-Month Dividend i₹9.00₹0.00
Last 12-Month Dividend Yield i2.98%N/A
3-Year Avg Annual Dividend i₹5.53₹0.00
3-Year Avg Dividend Yield i1.92%N/A
3-Year Total Dividends i₹16.60₹0.00
Ex-Dividend DateAug 01, 2025N/A